Lancet 377:19291937 Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR (2011) Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication
This is the most common thing patients say in their first month on GLP-1 therapy
Its a strategy of saying, All right, if we pop our head over the barbed wire fence, is anybody going to take a shot? Novo launched the drug in the beginning of January and has seen strong demand in the U.S., where it is available on its cash-pay direct-to-consumer website
Specifically, it works to prevent glycation the process where sugar molecules bind to collagen
J., Bin Rsheed, A
GLP-1 medications like Ozempic, Wegovy, and Mounjaro slow digestion on purpose thats part of how they keep you feeling full longer and help with blood sugar control